Takashi SATOMI
- Internal Medicine top 10%
- Oncology top 10%
- Pancreatic and Hepatic Oncology Research 2
- Inflammatory Biomarkers in Disease Prognosis 2
- Gastroenterology top 10%
-
- Breast Cancer Treatment Studies 2
-
- Metastasis and carcinoma case studies 2
-
- Gastrointestinal disorders and treatments 2
- Colorectal and Anal Carcinomas 2
-
- IgG4-Related and Inflammatory Diseases 1
-
- Takotsubo Cardiomyopathy and Associated Phenomena 1
- Co-authors
- Masayuki TatsutaSeizo MasutaniMasataka IkedaHiroshi ImamuraHideyuki IshidaHiroshi FurukawaJ ShimizuOsamu Ishikawa
- Journals
- SHILAP Revista de lepidopterología (1 paper)Annals of Surgical Oncology (2 papers)Cancer Chemotherapy and Pharmacology (1 paper)
- Partner nations
- JapanUnited States
In The Last Decade
Takashi SATOMI
14 papers receiving 413 citations
Peers
Comparison fields: 5 of 47
- Internal Medicine 43
- Oncology 278
- Gastroenterology 32
- Cancer Research 85
- Pulmonary and Respiratory Medicine 171
Countries citing papers authored by Takashi SATOMI
This map shows the geographic impact of Takashi SATOMI's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Takashi SATOMI with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Takashi SATOMI more than expected).
Fields of papers citing papers by Takashi SATOMI
This network shows the impact of papers produced by Takashi SATOMI. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Takashi SATOMI. The network helps show where Takashi SATOMI may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Takashi SATOMI, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2013 | 1 | |
| 2 | 2002 | 248 | |
| 3 | 2002 | 35 | |
| 4 | 2002 | 43 | |
| 5 | 2001 | 15 | |
| 6 | 2000 | 41 | |
| 7 | 2000 | 11 | |
| 8 | 2000 | 24 | |
| 9 | 1998 | 2 | |
| 10 | 1996 | 0 | |
| 11 | [Efficacy of combination therapy consisting of cyclophosphamide, adriamycin, UFT and oophorectomy/tamoxifen for advanced or recurrent breast cancer]. | 1994 | 1 |
| 12 | [A primary adenosquamous carcinoma of the stomach difficult to differentiate from gastric ulcer]. | 1990 | 1 |
| 13 | 1989 | 1 | |
| 14 | [Two cases of cloacogenic carcinoma of the anal canal: chemotherapeutic effect of cis-dichlorodiammine-platinum]. | 1988 | 2 |
| 15 | 1987 | 3 |
About Takashi SATOMI
Takashi SATOMI is a scholar working on Oncology, Cancer Research and Gastroenterology, having authored 15 papers that have together received 428 indexed citations. Recurring topics across this work include Gastrointestinal disorders and treatments (2 papers), Metastasis and carcinoma case studies (2 papers), Pancreatic and Hepatic Oncology Research (2 papers), Inflammatory Biomarkers in Disease Prognosis (2 papers), Breast Cancer Treatment Studies (2 papers), Colorectal and Anal Carcinomas (2 papers), IgG4-Related and Inflammatory Diseases (1 paper) and Takotsubo Cardiomyopathy and Associated Phenomena (1 paper). The work is most often cited by research in Internal Medicine (43 citations), Oncology (278 citations) and Gastroenterology (32 citations). Takashi SATOMI has collaborated with scholars based in Japan and United States. Frequent co-authors include Masayuki Tatsuta, Seizo Masutani, Masataka Ikeda, Hiroshi Imamura, Hideyuki Ishida, Hiroshi Furukawa, J Shimizu, Hiroshi Furukawa, Osamu Ishikawa and Masahiro Hiratsuka. Their work appears in journals such as SHILAP Revista de lepidopterología, Annals of Surgical Oncology and Cancer Chemotherapy and Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.